3//SEC Filing
La Jolla Pharmaceutical Holdings, LLC 3
Accession 0000920465-20-000131
CIK 0001373707other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:35 PM ET
Size
4.5 KB
Accession
0000920465-20-000131
Insider Transaction Report
Form 3
Holdings
- 1,085,000
Common Stock, par value $0.001 per share
Footnotes (1)
- [F1]The 1,085,000 shares of common stock of Tetraphase Pharmaceuticals, Inc. referenced herein represent shares that were previously purchased by La Jolla Pharmaceutical Company, a California corporation ("La Jolla"), through a series of open-market purchases made between June 10, 2020 and June 19, 2020 (as reported on a Statement of Beneficial Ownership on Schedule 13D filed with the SEC on June 22, 2020), which shares were subsequently contributed by La Jolla to its non-wholly owned subsidiary, La Jolla Pharmaceutical Holdings, LLC, a Delaware limited liability company, on July 23, 2020.
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001820670
Filing Metadata
- Form type
- 3
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 8:35 PM ET
- Size
- 4.5 KB